Finger-Prick test could replace needles for cancer blood monitoring
NCT ID NCT06183151
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new device that measures blood counts from a tiny finger-prick sample in cancer patients. Researchers will compare these results to standard lab tests from regular blood draws. The goal is to see if the device is accurate enough to eventually allow patients to monitor their blood counts more easily, possibly at home. The study involves 150 adults receiving cancer therapy and is currently on hold.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Entia Liberty System (device)
What this could lead to
If successful, this could lead to a simple finger-prick test for cancer patients to monitor their blood counts at home, reducing clinic visits.
What could go wrong
This is an early-stage device validation study with only 150 participants. The results are for research only and won't change patient care yet. The study is currently suspended.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor Scott & White - Temple
Temple, Texas, 76508, United States
-
North Wales Clinical Research Facility
Wrexham, Wrexham County Borough, LL13 7YP, United Kingdom
-
Queen Margaret Hospital
Dunfermline, Fife, KY12 0SU, United Kingdom